• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.14% Nasdaq Down0.35%

    Cellular Biomedicine Group Inc. (CBMG)

    -NasdaqGM
    23.55 Down 0.17(0.72%) 4:00PM EDT
    |After Hours : 23.55 Up 0.00 (0.02%) 4:29PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 564   205   274  
    Cost of Revenue213  296   -  
    Gross Profit 351   (91) 274  
    Operating Expenses
    Research Development2,672  1,891  3,214  
    Selling General and Administrative8,694  9,372  4,121  
    Non Recurring1,428   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (12,442) (11,354) (7,062)
    Income from Continuing Operations
    Total Other Income/Expenses Net87  (5)30  
    Earnings Before Interest And Taxes(12,355)(11,359)(7,032)
    Interest Expense -   -   -  
    Income Before Tax(12,355)(11,359)(7,032)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(12,355)(11,359)(7,032)
    Non-recurring Events
    Discontinued Operations(3,119)(2,439) -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (15,475) (13,797) (7,032)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (15,475) (13,797) (7,032)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.